Purchase Order 75N94020P00400

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Thermo Electron North America LLC for $11,578.02 on May 31, 2019. The order, classified as a firm fixed-price purchase order with no set-aside designation, obligated funds for scientific instrumentation or laboratory equipment support. Work is performed in Bethesda, Maryland. The order's ultimate completion date was June 4, 2020.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Regenstrief Institute Inc. for $9,844.90 on September 2, 2016, with ultimate completion on September 25, 2017. The order covers content development for expiring lines and carries firm fixed-price pricing with no set-aside. Place of performance is Bethesda, Maryland.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $8,361.40 on April 1, 2015. Work is performed in Bethesda, Maryland. The order was issued with no set-aside designation and carries a firm fixed-price structure. Ultimate completion is scheduled for April 10, 2015.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $11,681.56 on March 3, 2017. The order was firm fixed price with no set-aside. Performance occurred in Minneapolis, Minnesota. The order expired on May 31, 2017 and procured biological research materials and laboratory supplies, including proteins, antibodies, and assay kits for biomedical research support.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a purchase order to The Trustees of the University of Pennsylvania for $60,000.00 on August 31, 2026, to provide clinical cohorts with dataset and associated images for the base year, with an ultimate completion date of August 30, 2028. Work is performed in Philadelphia, Pennsylvania. The order is firm fixed price with no set-aside used.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a purchase order to Children's National Medical Center on September 16, 2019, with a ceiling value of $25,000.00. Place of performance is Washington, DC. The order is firm fixed price with an ultimate completion date of August 31, 2020. No set-aside category was applied.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Synteract, Inc. for $28,956.50 on November 20, 2018. The order was firm fixed price with no set-aside applied. Place of performance was Bethesda, Maryland. The contract expired on May 19, 2019.</p>

The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>